Vaccine offers hope against EBV-linked cancers and MS

Vaccine offers hope against EBV-linked cancers and MS

A cutting-edge vaccine candidate developed by QIMR Berghofer has achieved potent and durable immune protection against Epstein–Barr virus (EBV) in preclinical models, a breakthrough that could prevent the type of severe viral infection known to be a leading cause of...
Bivalent COVID booster better than 1-strain 4th dose

Bivalent COVID booster better than 1-strain 4th dose

CREDIT: NIH/NIAID cc A fourth dose of the bivalent (two-strain) COVID-19 vaccine is substantially more effective against medical treatment and hospitalization than a fourth monovalent (single-strain) dose among both previously infected and never-infected people who...
A chance to design better vaccines?

A chance to design better vaccines?

A new paper in Biology Methods & Protocols, published by Oxford University Press, shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19. In this study, the authors...